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 Abstract
Introduction: Identifying factors that can help move palliative care assessments upstream 
appears to be potentially beneficial for older cancer patients in the critical care setting.
Aim: This study aimed to determine the profile of older cancer patients admitted to the intensive 
care unit (ICU) and examine possible associations with criteria for a palliative care assessment.
Material and Methods: Data were collected on demographics and ICU outcome (death vs 
discharge) from patients aged ≥ 65 years with advanced cancer admitted to a general ICU from August 2013 to July 2014 in 
a single institution. Chronic conditions were scored using Charlson comorbidity index (CCI) and geriatric index of comorbidity 
(GIC). Severity of illness (prognosis) was assessed with simplified acute physiology score (SAPS3) and sequential organ failure 
assessment (SOFA), and performance status with Karnofsky performance scale (KPS) and palliative performance scale (PPS) 
on admission and day 7. Patients were screened for unmet palliative care needs on admission (PC1) and day 7 (PC2) using the 
Center to Advance Palliative Care primary/secondary criteria.
Results: Of 71 patients included, 52.1% were women; mean (SD) age was 76.9 (7.1) years. GIC scores were correlated with PC1 
(rs = 0.326, P = 0.005) and PC2 (rs = 0.262, P = 0.027). PC1 was correlated with prognostic scores (SAPS3: rs = 0.236, P = 0.047; 
SOFA: rs = 0.263; P = 0.027), while PC2 was correlated with both prognostic scores (SAPS3: rs = 0.321, P = 0.006; SOFA: 
rs = 0.343, P = 0.003) and performance status (KPS: rs = −0.413, P = 0.0003; PPS: rs = −0.505, P = 0.0001). Patients who died 
in the ICU (N  =  39, 54.9%) or were discharged (N = 32, 45.1%) differed significantly in performance status (KPS, P = 0.012; PPS, 
P = 0.005), but not in prognostic scores (SAPS3, P = 0.31; SOFA, P = 0.41) or comorbidity indices (CCI, P = 0.85; GIC, P = 0.94).
Conclusions: Our findings suggest that early palliative care should be integrated into intensive care to avoid potentially inappropriate 
interventions or procedures in older cancer patients admitted to the ICU with poor performance status and prognostic scores.
 Resumo
Introdução: A identificação de fatores que podem ajudar a antecipar as avaliações de cuidados 
paliativos parece ser potencialmente benéfica para pacientes idosos com câncer no ambiente 
de cuidados intensivos.
Objetivo: Este estudo teve como objetivo determinar o perfil de pacientes idosos com câncer 
admitidos na unidade de terapia intensiva (UTI) e examinar possíveis associações com critérios 
para avaliação de cuidados paliativos.
Material e métodos: Foram coletados dados sobre dados demográficos e resultado da UTI (óbito versus alta) de pacientes 
com idade ≥ 65 anos com câncer avançado admitidos em uma UTI geral, de agosto de 2013 a julho de 2014, em uma única 
instituição. As condições crônicas foram pontuadas usando o índice de comorbidade de Charlson (CCI) e o índice geriátrico 
de comorbidade (GIC). A gravidade da doença (prognóstico) foi avaliada com escore de fisiologia aguda simplificada (SAPS3) 
e avaliação sequencial de falência de órgãos (SOFA) e estado de funcionalidade com a escala de desempenho de Karnofsky 
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(KPS) e escala de desempenho paliativo (admissão e dia 7). A triagem para necessidades de cuidados paliativos não atendidos 
na admissão (PC1) e no dia 7 (PC2), utilizando os critérios primários/secundários do Center to Advance Palliative Care.
Resultados: Dos 71 pacientes incluídos, 52,1% eram mulheres; a idade média (DP) foi de 76,9 (7,1) anos. Os escores do GIC 
foram correlacionados com PC1 (rs = 0,326, P = 0,005) e PC2 (rs = 0,226, P = 0,027). PC1 foi correlacionado com escores 
prognósticos (SAPS3: rs = 0,236, P = 0,047; SOFA: rs = 0,263; P = 0,027), enquanto PC2 foi correlacionado com ambos os 
escores prognósticos (SAPS3: rs = 0,321, P = 0,006; SOFA: rs = 0,343, P = 0,003) e estados de funcionalidade (KPS: rs = -0,413, 
P = 0,0003; PPS: rs = -0,505, P = 0,0001). Os pacientes que morreram na UTI (N = 39, 54,9%) ou receberam alta (N = 32, 45,1%) 
diferiram significativamente no status de desempenho (KPS, P = 0,012; PPS, P = 0,005), mas não nos escores prognósticos 
(SAPS3, P = 0,31; SOFA, P = 0,41) ou índices de comorbidade (CCI, P = 0,85; GIC, P = 0,94).
Conclusões: Nossos achados sugerem que os cuidados paliativos precoces devem ser integrados aos cuidados intensivos 
para evitar intervenções ou procedimentos potencialmente inapropriados em pacientes idosos com câncer admitidos na UTI 
com baixo estado de funcionalidade e escores prognósticos.
 Introduction
Along with increased life expectancy, there has 
been a significant increase in the population of 
patients living with chronic life-limiting conditions, 
such as cancer. The number of new cancer cases 
is expected to rise dramatically over the next 2 
decades, since many risks for specific cancers 
increase with age.1
Great advances in life-sustaining medical 
technology have undoubtedly provided benefits by 
optimizing disease control; however, the possibility 
to prolong life should always be balanced against a 
person’s quality of life.2,3 Not rarely, the quality of 
existence is sacrificed – by using medical interventions 
– for the chance of gaining time later,4 which adds 
little or no benefit to terminally ill patients. In 
these cases, integrative palliative care should be 
prioritized, especially if such medical interventions 
are provided in the critical care setting.5-7 
The challenge of critical care physicians is to 
provide medical interventions that are not only 
helpful but also humane to patients on an individual 
basis.8-10 Concerns about the circumstances under 
which intensive care is applicable or whether there 
is room for palliative care should be addressed, 
focusing on the demands of the ill person and 
family members rather than limiting care to the 
illness, especially in intensive care units (ICUs) of 
low- and middle-income countries such as Brazil, 
where palliative care remains underdeveloped.11-13
The provision of palliative care in the Brazilian 
public health system is governed by Resolution No. 
41, dated of October 31, 2018, published in the 
Federal Official Gazette of November 23, 2018, which 
provides guidelines for the organization of palliative 
care in light of integrated continued care at any 
stage of the health care delivery process, including 
hospital care.14 However, to date, palliative care has 
not been well integrated with or incorporated into 
the management of chronic life-limiting conditions 
in Brazilian ICUs. For instance, older cancer patients 
with terminal illness often prefer palliative over 
life-extending care and also prefer home as a place 
of death.15 Nevertheless, these patients are often 
hospitalized and actually die in the hospital, despite 
their willingness to remain at home.16-20 These deaths 
are usually preceded by decisions to withhold 
or withdraw life-sustaining treatment,21 decisions 
which are often hindered by prognostic uncertainty. 
Therefore, our motivation for conducting this study 
was to demonstrate that, although palliative care 
services are not actually implemented in Brazilian 
ICUs, there is a high demand for these services 
in the critical care setting, making their provision 
imperative.
In view of the foregoing, recognition of factors that 
can help move palliative care assessments upstream 
for older cancer patients appears to be potentially 
beneficial for both patients and physicians. Therefore, 
the aim of this study was to determine the profile 
of older cancer patients admitted to a general ICU 
and examine possible associations with criteria for 
a palliative care assessment in order to provide 
data that may serve as the grounds for actually 
implementing palliative care in the Brazilian health 
care system, in accordance with Resolution No. 41.
 Material and Methods 
Design and setting
We conducted a prospective observational study 
of older cancer patients admitted to the general ICU 
from August 2013 to July 2014 in a single institution. 
Eligible participants were all patients aged ≥ 65 years 
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with a diagnosis of advanced cancer. Patients who 
died within 24 hours of ICU admission and those 
transferred to other hospitals were excluded.
The study setting was an 11-bed medical-surgical 
ICU in a large private hospital providing tertiary care 
in the city of Rio de Janeiro, Brazil. The hospital 
has 350 beds, of which 112 are in ICUs, with 50-70 
new admissions per month. Persons 65 years and 
older account for approximately 65% of all patients 
admitted, and approximately 30% of cases are cancer-
related (10% locoregional, 20% hematologic and/
or metastatic). The study was approved by the 
Research Ethics Committee of the institution (number: 
466.896) via Plataforma Brasil (www.saude.gov.br/
plataformabrasil), under Ethics Approval Certificate 
number 22679513.0.0000.0062. Informed consent 
was waived due to the non-interventional design 
of the study. All investigators signed a data use 
agreement to ensure the ethical and secure use of 
the data.
Data sources and outcomes
Demographic data, disease-related data, and ICU 
outcome were recorded prospectively. Outcome was 
measured as death or ICU discharge. Nosologic data 
were collected in an automated database system as 
part of the ICU routine (EpiMed Monitor System; 
EpiMed Solutions, Rio de Janeiro, RJ, Brazil). The 
complete set of data collected included information on 
diagnosis, severity of illness (prognosis), performance 
status, readmissions, complications, minor surgical 
interventions, imaging tests, laboratory tests, antibiotic 
use, blood transfusion, cardiac arrest and need for 
cardiopulmonary resuscitation (CPR) maneuvers, 
presence of do-not-resuscitate (DNR) orders, and 
length of stay (LOS) in hospital and ICU.
Chronic conditions were scored using the Charlson 
comorbidity index (CCI) and the geriatric index of 
comorbidity (GIC). Elevated CCI scores are associated 
with increased mortality, with a maximum score 
of 37 (a ratio was calculated to estimate 10-year 
survival [%]). Patients were classified according to 
severity scores (sequential organ failure assessment 
[SOFA] and simplified acute physiology score [SAPS 
3]) and performance status (Karnofsky performance 
scale [KPS] and palliative performance scale [PPS]), 
which were measured at the time of admission and 
7 days after admission.
The primary and secondary criteria developed by 
the Center to Advance Palliative Care (CAPC)22 were 
used to screen patients for unmet palliative care 
needs at the time of admission (PC1) and on ICU 
day 7 (PC2). Briefly, the CAPC developed 2 checklists 
containing primary and secondary criteria, one to be 
used for screening at the time of admission aiming 
to identify patients whose conditions clearly warrant 
a basic palliative care assessment and one for daily 
patient rounds, aiming to identify evolving patient 
issues that may trigger the need for a basic palliative 
care assessment. Primary criteria are global in nature 
and should be used as the minimum expected 
standard of care (e.g., frequent admissions), while 
secondary criteria are more specific and should 
be used as supplementary criteria to implement 
a more comprehensive systems-change approach 
(e.g., cognitively impaired and transplant-ineligible 
patients).22
In the present study, primary criteria accounted for 
5 items in both checklists, while secondary criteria 
accounted for 8 items in the checklist applied at 
the time of admission (PC1; total of 13 items) and 
5 items in the checklist applied on ICU day 7 (PC2; 
total of 10 items) (Additional file 1). For analysis 
purposes, 1 point was given for each (primary and 
secondary) criterion if present, and a total score 
was obtained by summing the points assigned to 
present criteria. Therefore, the maximum total score 
was 13 for the PC1 checklist and 10 for the PC2 
checklist. Of note, the purpose of summing these 
criteria was solely to illustrate quantitatively the 
potential demand for palliative care services, and 
not to suggest that patients meeting more criteria 
have more unmet needs—since meeting any of these 
criteria is grounds for a palliative care assessment 
for potentially unmet needs.
PC1 and PC2 scores were correlated with severity 
scores, performance status, LOS, and laboratory 
variables. Patients were then divided into 2 groups 
according to outcome (death or ICU discharge) for 
comparison.
Sample size
Sample size was calculated based on a pilot study 
of 20 cases.23 With a 5% significance level and a 
power of 80%, a sample size of at least 84 patients 
was needed to detect a correlation of 0.30 or 46 
patients to detect a correlation of 0.40 between PC1/
PC2 scores and severity scores/performance status. 
Therefore, this study was designed with a target 
sample size of at least 65 patients.
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Data analysis
Quantitative data were expressed as mean (SD), 
median and interquartile range (IQR), and minimum 
and maximum values, while categorical data were 
expressed as frequency (n) and percentage (%). 
Nonparametric tests were used when data were not 
normally distributed (Shapiro-Wilk test). Spearman’s 
correlation coefficients (rs) were calculated to assess 
the degree of association of PC1 and PC2 scores with 
quantitative variables. Comparisons between the 2 
groups (death vs ICU discharge) were performed 
by Student’s t test for independent samples, the 
Mann-Whitney test for quantitative data, and the 
chi-square test or Fisher’s exact test for categorical 
data. Data were analyzed using SAS version 6.11 
(SAS Institute, Inc., Cary, NC, USA), and a P-value 
≤ 0.05 was considered significant.
 Results
A total of 71 older cancer patients admitted to 
the general ICU between August 2013 and July 2014 
were included in the study. Of these, 37 (52.1%) 
were women and 34 (47.9%) were men. Mean (SD) 
patient age was 76.9 (7.1) years. Gastrointestinal 
cancer was the most common type of malignancy 
(N = 26, 36.6%), followed by urinary tract cancer 
(N = 15, 21.1%). The median time since the diagnosis 
of cancer was 242 days (IQR, 30-1277.5 days; min-
max, 1-5110 days). As for ICU outcome, 39 (54.9%) 
patients died and 32 (45.1%) were discharged from 
the ICU. The main causes of death were infection, 
sepsis, and septic shock, with pneumonia as the 
most frequent diagnosis (N = 13, 33.3%), followed 
by urinary tract infection (N = 7, 17.9%). The main 
characteristics of the study population are shown in 
Table 1. A complete data set of this table is available 
as supplementary material (Additional file 2).
GIC scores were correlated with both PC1 (rs = 0.326, 
P = 0.005) and PC2 (rs = 0.262, P = 0.027). PC1 was 
correlated with prognostic scores (SAPS 3: rs = 0.236, 
P = 0.047; SOFA: rs = 0.263; P = 0.027), while PC2 
was correlated with both prognostic scores (SAPS 
3: rs = 0.321, P = 0.006; SOFA: rs = 0.343, P = 0.003) 
and performance status (KPS: rs = −0.413, P = 0.0003; 
PPS: rs = −0.505, P = 0.0001) (Table 2).
Table 3 shows the results of the comparison of 
clinical variables, laboratory variables, and scores 
between patients divided by ICU outcome. There was 
Table 1 – Main characteristics of the study population (N = 71)
Variable Mean (SD) Median (IQR) Min-max
Age, years 76.9 (7.1) 77 (72-83) 65-93
ICU length of stay, days 8.20 (9.45) 6 (4-9) 1-73
Hospital length of stay, days 22.0 (22.4) 16 (10-26) 2-155
SAPS 3, score 60.2 (11.2) 60 (54-65) 36-91
Probability of death, % 43.3 (21.8) 40.4 (25.7-57.8) 4.01-85.8
SOFA, score 3.21 (3.13) 2 (1-5) 0-14
Karnofsky performance scale, % 31.3 (11.8) 30 (20-40) 10-80
Palliative performance scale, % 30.7 (15.1) 30 (20-40) 10-80
Charlson comorbidity index, score 5.58 (3.12) 5 (3-8) 2-17
10-year survival, % 45.5 (28.3) 21 (21-77) 21-90
Geriatric index of comorbidity, score 10.3 (3.7) 10 (8-12) 2-21
PC1, total score (max. 13) 6.39 (1.18) 7 (6-7) 3-9
PC2, total score (max. 10) 5.96 (1.20) 6 (5-7) 3-8
Creatinine, mg/dL 1.61 (1.27) 1.17 (0.79-2.13) 0.17-6.06
Albumin*, g/dL 2.70 (0.62) 2.7 (2.2-3.1) 1.4-4.1
Total bilirubin†, mg/dL 0.87 (1.19) 0.46 (0.33-0.78) 0.14-5.58
Lymphocytes, % 19.3 (16.4) 15 (10-25) 2-100
Hemoglobin, g/dL 9.70 (2.34) 9.5 (8.1-11.5) 5-15
ICU, intensive care unit; IQR, interquartile range (Q1-Q3); PC1, palliative care checklist applied at the time of admission; PC2, palliative care checklist 
applied on ICU day 7; SAPS 3, simplified acute physiology score; SD, standard deviation; SOFA, sequential organ failure assessment.
* Data were available for only 65 (91.5%) patients.
† Data were available for only 64 (90.1%) patients.
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no significant difference between death (N = 39) and 
ICU discharge (N = 32) groups in prognostic scores 
(SAPS 3, P = 0.31; SOFA, P = 0.41) or comorbidity 
indices (CCI, P = 0.85; GIC, P = 0.94). However, 
the 2 groups differed significantly in performance 
status (KPS, P = 0.012; PPS, P = 0.005). 
Although mean PC1 and PC2 scores did not differ 
between the 2 groups (Table 3), some specific 
criteria differed significantly between the groups 
when analyzed individually: at the time of admission 
(PC1) – the primary criterion “5. Decline in function, 
feeding intolerance, or unintended weight loss (e.g., 
failure to thrive)” (death: 37 [94.9%] vs discharge: 
25 [78.1%], P = 0.039) and the secondary criterion 
“8. Metastatic or locally advanced incurable cancer” 
(death: 36 [92.3%] vs discharge: 22 [68.8%], P = 0.012); 
on ICU day 7 (PC2) – the secondary criterion “8. 
Patient / family / surrogate request for palliative care” 
(death: 8 [20.5%] vs discharge: 0 [0.0%], P = 0.006).
Additionally, more patients undergoing surgery 
died in the ICU (death: 9 [23.1%] vs discharge: 
2 [6.3%], P = 0.049). Patients currently receiving 
treatment were discharged more frequently (death: 
13 [33.3%] vs discharge: 18 [56.3%], P = 0.053), 
especially those receiving chemotherapy (death: 7 
[18.0%] vs discharge: 14 [43.8%], P = 0.018); there 
was no difference in ICU outcome between patients 
receiving radiotherapy (death: 3 [7.7%] vs discharge: 
3 [9.4%], P = 0.56). As for complications, the groups 
differed in the occurrence of cardiac arrest (death: 
9 [23.1%] vs discharge: 1 [3.1%], P = 0.016) and 
delirium (death: 5 [12.8%] vs discharge: 11 [34.4%], 
P = 0.031). In addition, patients who died in the ICU 
had significantly more DNR orders (death: 25 [64.1%] 
vs discharge: 10 [31.3%], P = 0.006) and significantly 
greater use of vasoactive amines (death: 17 [43.6%] 
vs discharge: 5 [15.6%], P = 0.011), mechanical 
ventilation (death: 15 [38.5%] vs discharge: 3 [9.4%], 
P = 0.005), and feeding tubes (death: 22 [56.4%] 
vs discharge: 7 [21.9%], P = 0.003). All patients 
underwent laboratory and imaging investigations 
as part of the ICU routine.
 Discussions
The findings of the present study showed that 
patients with advanced cancer aged 65 years and 
older were routinely admitted to the ICU with 
continued care, without integrating palliative care 
services into oncology care. In our sample, older 
cancer patients, especially women, stayed a median 
of 6 days in the ICU, with prolonged hospital stay 
(median of 16 days), without receiving palliative 
care during the course of the disease. Based on 
the collected data, all patients received curative or 
disease-modifying treatments, with no palliative care 
being reported at any stage of the illness. However, 
the cancer had been diagnosed approximately 8 
months before ICU admission, a long enough period 
to initiate advance care planning discussions,24,25 as 
Table 2 – Correlations between PC1 and PC2 scores and study 
variables
Variable PC1 PC2
ICU length of stay, days
rs 0.029 0.688
P 0.81 0.0001












Karnofsky performance scale, %
rs −0.204 −0.413
P 0.088 0.0003
Palliative performance scale, %
rs −0.187 −0.505
P 0.12 0.0001


























ICU, intensive care unit; PC1, palliative care checklist applied at the time of 
admission; PC2, palliative care checklist applied on ICU day 7; rs, Spearman’s 
correlation coefficient; SAPS 3, simplified acute physiology score; SOFA, 
sequential organ failure assessment.
* Data were not available for 6 patients.
† Data were not available for 7 patients.
Bold indicates significant values.
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well as discussions about prognosis, care options, 
and understanding of advance directives that address 
goals of care under critical conditions.16, 26, 27
In many critical care instances, medical progress 
may do little more than prolong the death process 
for older cancer patients, which is accompanied by 
intense emotional distress and substantial economic 
burden (both on the patient/family and the health 
system).21, 28, 29 More than 40% of our sample were 
subjected to further treatments by radiotherapy 
(8.5%) or chemotherapy (29.6%), or even by surgery 
(14.1%), despite previous treatments and high severity 
scores, organ dysfunctions, and median performance 
status of 30% on ICU admission. When the analysis 
was stratified by ICU outcome, death in the ICU 
was significantly more common among patients 
undergoing surgery (P = 0.049), but those receiving 
chemotherapy were more frequently discharged from 
the ICU (P = 0.018). It is worth noting that this is an 
observational study; therefore, the interventions were 
performed at the discretion of the health care team, 
with the collected data being only analyzed here. The 
same applies to the lower rates of delirium observed 
in patients who died vs discharged. Delirium is 
associated with high morbidity, and the observed 
rates should raise concerns about providing adequate 
care to prevent delirium. 
Moreover, based on the results of the checklist 
applied on ICU day 7 (PC2), all 8 patients whose 
family or surrogate had requested palliative care died 
without receiving any palliative care services. These 
data support the argument that, especially in a low-
to-middle income scenario, patients who die in the 
ICU are still subjected to a wide range of treatments 
without even considering the benefits of palliative 
care. Therefore, taking into account the risks of 
the treatments offered (surgery, chemotherapy, and 
radiotherapy), early integration of palliative care 




Death (N = 39) Discharge (N = 32)
Age, years, mean (SD); median 76.5 (7.3); 76 77.5 (6.8); 77 0.49
Sex, n (%)
Male 17 (43.6) 17 (53.1)
0.42
Female 22 (56.4) 15 (46.9)
ICU length of stay, days, mean (SD); median 9.51 (12.28); 6 6.59 (3.50); 6 0.76
Hospital length of stay, days, mean (SD); median 23.3 (19.1); 16 20.5 (26.2); 13.5 0.41
SAPS 3, score, mean (SD); median 61.5 (11.0); 62 58.7 (11.3); 59.5 0.31
Probability of death, %, mean (SD); median 46.0 (22.5); 42.9 39.9 (20.8); 38.9 0.29
SOFA, score, mean (SD); median 3.51 (3.36); 2 2.84 (2.82); 2 0.41
Karnofsky performance scale, %, mean (SD); median 29.0 (13.1); 30 34.1 (9.5); 30 0.012
Palliative performance scale, %, mean (SD); median 26.7 (16.8); 30 35.6 (11.1); 40 0.005
Charlson comorbidity index, score, mean (SD); median 5.62 (3.03); 5 5.53 (3.27); 5 0.85
10-year survival, %, mean (SD); median 46.1 (29.3); 21 44.7 (27.4); 21 0.82
Geriatric index of comorbidity, score, mean (SD); median 10.4 (4.4); 10 10.1 (2.6); 10 0.94
Geriatric index of comorbidity, class IV, n (%) 37 (94.9) 25 (78.1) 0.039
PC1, total score (max. 13), mean (SD); median 6.38 (0.96); 7 6.41 (1.41); 7 0.72
PC2, total score (max. 10), mean (SD); median 6.18 (1.12); 6 5.69 (1.26); 6 0.12
Laboratory parameters, mean (SD); median
Creatinine, mg/dL 1.57 (1.19); 1.24 1.65 (1.38); 1.14 0.95
Albumin, g/dL 2.53 (0.62); 2.5 2.90 (0.57); 2.8 0.031
Total bilirubin, mg/dL 0.841 (1.272); 0.4 0.911 (1.101); 0.5 0.16
Lymphocytes, % 16.6 (13.5); 13 22.7 (19.1); 19 0.048
Hemoglobin, g/dL 9.42 (2.45); 8.8 10.1 (2.19); 10 0.26
ICU, intensive care unit; PC1, palliative care checklist applied at the time of admission; PC2, palliative care checklist applied on ICU day 7; SAPS 3, 
simplified acute physiology score; SD, standard deviation; SOFA, sequential organ failure assessment. 
Bold indicates a significant difference.
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into curative care (in this case, intensive care) may 
contribute to improving communication about end-
of-life care goals, to properly aligning treatments 
with care planning and advance directives, and to 
improving the patient’s quality of life and patient/
family psychosocial support, as well as reducing 
health care utilization, regardless of disease prognosis 
or treatment goals.21, 30-34
Among the correlations found with the CAPC 
criteria used on admission (PC1) and ICU day 7 
(PC2), we highlight a significant moderate direct 
correlation between PC2 and ICU LOS (rs = 0.688, 
P = 0.0001), indicating that patients who stayed 
longer in the ICU were most in need of palliative care 
assessment. Significant moderate inverse correlations 
were observed between PC2 and performance scale 
scores, especially PPS (rs = −0.505, P = 0.0001), 
indicating that better preserved performance reduced 
the need of palliative care assessment. Also, although 
weak, direct correlations with SOFA scores (PC2, 
rs = 0.343) and GIC scores (PC1, rs = 0.326; PC2, 
rs = 0.027) indicated that patients with worse prognosis 
and more comorbidities had greater palliative care 
needs. In this respect, palliative care should be 
seen as a component of rather than an alternative 
to critical care, and these services should be offered 
even when life-sustaining treatment is continuing.7 
Also of note is a study by Weijers et al.35 which 
evaluated whether adding a second, more specific 
“surprise question” to the CAPC checklist, referring 
to “living” rather than “dying” (“Would I be surprised 
if this patient is still alive after 12 months?”), would 
prompt general practitioners to plan for anticipatory 
palliative care in case the classical surprise question 
(“Would I be surprised if this patient were to die in 
the next 12 months?”) is answered negative. They 
concluded that the combination of the 2 “surprise 
questions” appears to contribute to more extensive 
and anticipatory palliative care planning for those 
patients of whom general practitioners would be 
surprised if they were still alive after 12 months, being 
considered a helpful additional tool to determine 
the right moment to start palliative care planning.
The correlations found in the present study may 
help identify, in advance, older cancer patients in 
the ICU at high risk for unmet palliative care needs, 
thus increasing access to palliative care services 
integrated with oncology care and ensuring dignity-
conserving care.36 Also, a well-planned integration 
of palliative care in health systems can improve 
service performance.37-40 For older cancer patients, the 
presence of an inpatient palliative care unit within 
the hospital may improve patients’ quality of life 
by, at least in part, reducing anticancer therapy and 
life-sustaining treatments that are no longer beneficial 
due to disease progression or poor performance, in 
addition to reducing costs.41-43 Although data from 
low- and middle-income countries are scarce, it 
appears that the up-front costs required to integrate 
patient-centered palliative care services into the 
health system, such as development of policies, 
purchase of essential medicines, and staff training/
development, ultimately “pay off” over time by 
improving patient outcomes, decreasing health care 
expenses, and reducing the overuse of hospital 
resources and nonbeneficial interventions.44
This study has some limitations. Because it is 
a single-center study, our findings may not be 
generalizable to a larger group of patients or 
providers. Patients with advanced cancer were 
included regardless of tumor type, site, or specific 
staging, which can also be seen as a limitation 
of this study. However, their inclusion did not 
compromise the homogeneity of the sample. 
Actually, the sample obtained allowed us to verify 
that many older cancer patients are still routinely 
admitted to the ICU for curative treatment, but the 
possibility of offering palliative care in conjunction 
with intensive care is overlooked. Although many 
of these patients met the criteria for early palliative 
care referral, there was still an excessive use of—
not always beneficial—resources and interventions, 
particularly of mechanical ventilation, vasoactive 
amines, antimicrobials, additional tests, and CPR 
maneuvers. Some of these patients should have 
received care in specialized units able to meet their 
real needs, thus ensuring the provision of dignified 
care to older cancer patients under critical conditions 
[3] and optimizing ICU bed utilization to serve the 
needs of patients actually meeting the criteria for 
this level of care. 
 Conclusion
For older cancer patients admitted to the ICU 
with poor performance status and prognostic scores, 
possible life-prolonging treatments may constitute not 
a benefit but rather a burden in the face of likely 
death, suggesting that early palliative care should 
be integrated into intensive care in order to avoid 
potentially inappropriate interventions or procedures. 
There is an urgent need to review the care provided 
to older cancer patients in the Brazilian health care 
system, especially in the ICU setting, highlighting the 
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moral implications involved in making end-of-life 
decisions, the increasing demand for palliative care 
in view of the risk of therapeutic obstinacy, and the 
evident lack of an integrated model of palliative 
care in the critical care setting.
List of abreviations
CAPC Center to Advance Palliative Care
CCI Charlson comorbidity index
CCI Charlson comorbidity index
CPR cardiopulmonary resuscitation
DNR do-not-resuscitate
GIC geriatric index of comorbidity
GIC geriatric index of comorbidity
ICU intensive care unit
KPS Karnofsky performance scale
LOS length of stay
PPS palliative performance scale
SAPS3 simplified acute physiology score
SOFA sequential organ failure assessment
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Supplementary File 1 – Criteria for a palliative care assessment in patients aged ≥ 65 years with cancer admitted to the intensive care 
unit (ICU).
AT THE TIME OF ADMISSION (PC1 checklist)
A potentially life-limiting or life-threatening condition and…
Primary criteria (give 0 if absent or 1 if present)
1. The “surprise question”: ‘Would I be surprised if this patient died within 12 months or earlier?’ ( )
2. Frequent admissions (e.g., more than 1 admission for the same condition within months) ( )
3. Admission prompted by difficult-to-control physical or psychological symptoms (e.g., moderate-to-severe symptom intensity 
for more than 24-48 hours) ( )
4. Complex care requirements (e.g., functional dependency, complex home support for ventilator / antibiotics / feedings) ( )
5. Decline in function, feeding intolerance, or unintended weight loss (e.g., failure to thrive) ( )
Secondary criteria (give 0 if absent or 1 if present)
6. Admission from long-term care facility or medical foster home ( )
7. Cognitively impaired older patient with acute hip fracture ( )
8. Metastatic or locally advanced incurable cancer ( )
9. Chronic home oxygen use ( )
10. Out-of-hospital cardiac arrest ( )
11. Current or past hospice program enrollee ( )
12. Limited or no social support (e.g., family stress, chronic mental illness) ( )
13. No history of completing an advance care planning discussion / document ( )
Total score: ( )
ON ICU DAY 7 (PC2 checklist)
A potentially life-limiting or life-threatening condition and…
Primary criteria (give 0 if absent or 1 if present)
1. The “surprise question”: ‘Would I be surprised if this patient died within 12 months or earlier?’ ( )
2. Difficult-to-control physical or psychological symptoms (e.g., more than 1 admission for the same condition within months) ( )
3. ICU length of stay ≥ 7 days ( )
4. Lack of Goals of Care clarity and documentation (goals of care: physical, social, spiritual, or other patient-centered goals) ( )
5. Disagreements or uncertainty among the patient, staff, and/or family (e.g., medical treatment decisions / resuscitation 
preferences / oral feeding and hydration) ( )
Secondary criteria (give 0 if absent or 1 if present)
6. Awaiting or deemed ineligible for solid-organ transplantation ( )
7. Patient / family / surrogate emotional, spiritual, or relational distress ( )
8. Patient / family / surrogate request for palliative care ( )
9. Patient is considered a potential candidate, or medical team is considering seeking consultation, for: feeding tube placement; 
tracheostomy; dialysis; ethics concerns; placement of automated implantable cardioverter-defibrillator; indication for long-term 
acute care hospital or medical foster home disposition ( )
10. Bone marrow transplantation (high-risk patients) ( )
Total score: ( )
Adapted from Weissman & Meier [19].
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Supplementary File 2 – Characteristics of the study population (N = 71).
Quantitative variables Mean (SD) Median (IQR) Min-max
Age, years 76.9 (7.1) 77 (72-83) 65-93
Time since diagnosis*, days 1012 (1442) 242 (30-1277.5) 1-5110
ICU length of stay, days 8.20 (9.45) 6 (4-9) 1-73
Hospital length of stay, days 22 (22.4) 16 (10-26) 2-155
SAPS 3, score 60.2 (11.2) 60 (54-65) 36-91
Probability of death, % 43.3 (21.8) 40.4 (25.7-57.8) 4.01-85.8
SOFA, score 3.21 (3.13) 2 (1-5) 0-14
Karnofsky performance scale, % 31.3 (11.8) 30 (20-40) 10-80
Palliative performance scale, % 30.7 (15.1) 30 (20-40) 10-80
Charlson comorbidity index, score 5.58 (3.12) 5 (3-8) 2-17
10-year survival, % 45.5 (28.3) 21 (21-77) 21-90
Geriatric index of comorbidity, score 10.3 (3.7) 10 (8-12) 2-21
PC1, total score (max. 13) 6.39 (1.18) 7 (6-7) 3-9
PC2, total score (max. 10) 5.96 (1.20) 6 (5-7) 3-8
Creatinine, mg/dL 1.61 (1.27) 1.17 (0.79-2.13) 0.17-6.06
Albumin*, g/dL 2.70 (0.62) 2.7 (2.2-3.1) 1.4-4.1
Total bilirubin†, mg/dL 0.87 (1.19) 0.46 (0.33-0.78) 0.14-5.58
Lymphocytes, % 19.3 (16.4) 15 (10-25) 2-100
Hemoglobin, g/dL 9.70 (2.34) 9.5 (8.1-11.5) 5-15








Hormone therapy 0 0.0




Hormone therapy 5 7.0




Geriatric index of comorbidity, class IV 62 87.3
Heart disease 4 5.6
Lung disease 4 5.6
Kidney disease 4 5.6
Liver disease 2 2.8
Dementia disorders 6 8.5
Frailty 7 9.9
PC1, present criteria
Item 1 70 98.6
Item 2 42 59.2
Item 3 68 95.8
Item 4 63 88.7
Item 5 62 87.3
Item 6 5 7.0
Item 7 1 1.4
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Item 8 58 81.7
Item 9 0 0.0
Item 10 0 0.0
Item 11 0 0.0
Item 12 16 22.5
Item 13 69 97.2
PC2, present criteria
Item 1 70 98.6
Item 2 61 85.9
Item 3 34 47.9
Item 4 69 97.2
Item 5 63 88.7
Item 6 0 0.0
Item 7 63 88.7
Item 8 8 11.3
Item 9 55 77.5
Item 10 0 0.0
Surgery 11 15.5
Complications
Cardiac arrest 10 14.1
Cardiopulmonary resuscitation 5 7.0
Adverse events 7 9.9
Delirium 16 22.5
Pressure ulcer 4 5.6
Atrial fibrillation 8 11.3
Multidrug-resistant organisms 7 9.9
Seizure 4 5.6
ICU readmission 17 23.9
Laboratory tests 71 100
Imaging tests 71 100
Vasoactive amines 22 31.0
Cardiac device 2 2.8
Packed red blood cell transfusion 10 14.1
Antibiotic therapy 50 70.4
Mechanical ventilation 18 25.4
Tracheostomy 6 8.5
Hemodialysis 4 5.6
Feeding tube 29 40.8
Parenteral nutrition 3 4.2
Gastrostomy 2 2.8
Electroencephalography 4 5.6
ICU, intensive care unit; IQR, interquartile range (Q1-Q3); PC1, palliative care checklist applied at the time of admission; PC2, palliative 
care checklist applied on ICU day 7; SAPS 3, simplified acute physiology score; SD, standard deviation; SOFA, sequential organ failure 
assessment.
* Data were available for only 65 (91.5%) patients.
† Data were available for only 64 (90.1%) patients. 
